Viewing Study NCT05105906


Ignite Creation Date: 2025-12-26 @ 11:00 AM
Ignite Modification Date: 2025-12-31 @ 8:15 PM
Study NCT ID: NCT05105906
Status: COMPLETED
Last Update Posted: 2025-03-13
First Post: 2021-09-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Post-operative Delirium (POD) in Patients Undergoing Hip Fracture Surgery
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organization:

Study Overview

Official Title: Post-operative Delirium (POD) Assessment in Patients Undergoing Hip Fracture Surgery
Status: COMPLETED
Status Verified Date: 2025-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The primary endpoint of the study is the appearance of Post Operative Delirium within the first 3 months.

The secondary endpoints are the development of POCD, dementia of any type of new onset at 12 months, mortality at 30 days, postoperative hospitalization time (including rehabilitation performed within the Polyclinic).. The analysis of the risk factors of POD and their correlation with the development of POCD/Dementia in the post-surgery period will provide important information for the optimization of the management path of these patients at an individual level , with inevitable repercussions on the possibility of reintegration into social and family life
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: